Our researchers are fighting the coronavirus pandemic with innovative approaches. With your donation you can support them in developing drugs and vaccines against the virus or in deciphering the mechanisms of disease development and progression. Here you can find out all about donation opportunities.
Learn more about how the HZI, with its translational focus, will help to facilitate a faster and more targeted approach when it comes to fighting and preventing existing, emerging or recurring infectious diseases.
Here you can find out more about the scientific results of the HZI in the research topics ”Bacterial and Viral Pathogens”, “Immune Response and Interventions” and “Anti-Infectives”.
Around 900 employees in research, administration and infrastructure, and about 220 visiting scientists from 40 different countries are employed at the Helmholtz Centre for Infection Research. To ensure top quality research we need top quality employees. Your creativity and innovative capabilities are the basis for the long-term success of our work. That's why we undertake a great deal to attract the best people to us. Learn more about this.
We communicate also through social media. Join our Facebook page, follow us on Twitter or subscribe to our YouTube-Channel.
The coronaviruses are a family of viruses that includes a series of very different pathogens. These viruses usually infect mammals, rodents, and birds, but only few coronaviruses adapted to humans. They did this with great success: About one third of all typical "common colds" and some cases of diarrhoea as well are caused by these RNA Viruses, which are the largest of their kind. We have compiled more information about the coronaviruses for you.
With the pathogen SARS-CoV-2, a novel virus that can cause respiratory diseases and pneumonia has been spreading worldwide since the end of 2019. Here we will keep you informed about current developments in research and provide answers to the most important questions.
HomePressPress Releases & News
Results 1 to 10 of total 553
Study by the HZI shows how a herpesvirus on the one hand rests inactive in connective tissue cells and on the other hand can replicate in the same cells when needed
Researchers at Helmholtz Institute Würzburg discover potential new antiviral targets in HIV-1
Bioinformatics specialists explore the molecular mechanisms of ageing
New HZI study shows efficacy of the natural product chlorotonil A against dormant stages of the Clostridioides difficile bacterium
Immunologist receives 1.5 million euros in funding
Discovery of two novel classes of natural products with activity against RNA viruses
CiiM team analyses genetic and epigenetic regulators
Head of Epidemiology at the HZI takes over a new department at the World Health Organisation in Geneva
Helmholtz Association funds interdisciplinary collaboration between two of its Research Fields
HIRI and HZI research team develop approach that increases efficiency of genome editing
You can also find a selection of our press releases on the page of Informationsdienst Wissenschaft